Evidence map›Paper›PMID 42334588›Full record

ArticleApplied microbiology and biotechnology2026

Impact of soybean meal enzymatic treatment on chicken caecal microbiota and intestinal epithelial cells.

Lauriane Plouhinec, Marc Maresca, Julie Saget, Virginie Neugnot, Estelle Devillard, Jean-Guy Berrin, Mickael Lafond

Abstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lauriane PlouhinecAix-Marseille Université, INRAE, BBF, Biodiversité et Biotechnologie Fongiques, Marseille, 13009, France.
Marc MarescaAix-Marseille Université, CNRS, Centrale Marseille, iSM2, Marseille, 13013, France.
Julie SagetAdisseo France S.A.S., European R&I Centre ELISE, Saint-Fons, 69190, France.
Virginie NeugnotAdisseo France S.A.S, CINAbio, INSA Toulouse, Toulouse, 31400, France.
Estelle DevillardAdisseo France S.A.S., European R&I Centre ELISE, Saint-Fons, 69190, France.
Jean-Guy BerrinAix-Marseille Université, INRAE, BBF, Biodiversité et Biotechnologie Fongiques, Marseille, 13009, France. jean-guy.berrin@inrae.fr.
Mickael LafondAix-Marseille Université, INRAE, BBF, Biodiversité et Biotechnologie Fongiques, Marseille, 13009, France. michael.lafond@univ-amu.fr.ORCID https://orcid.org/0000-0003-2646-0286

Funding

Association Nationale Recherche Technologie - CIFRE Grant no. 2021/1432
6 · The paper itself

Abstract

As demand for sustainable and welfare-conscious food production increases, reducing the environmental and health impacts of animal feed has become a key challenge. Soybean meal (SBM) is widely used in poultry diets for its high protein content, but its richness in non-starch polysaccharides (NSPs) can hamper its digestibility. To address this issue, a common strategy involves the utilization of enzymatic cocktails rich in carbohydrate-active enzymes (CAZymes). While these feed additives are specifically designed to degrade NSPs and enhance SBM protein digestibility, only scarce information is available on their impact on intestinal health. In this study, using intestinal epithelial cells lines, we show that pre-treatment of SBM by the enzymatic cocktail Rovabio™ Advance, supplemented or not with pectin-active fungal secretomes, did not alter epithelial integrity nor induce inflammatory responses. Additionally, in vitro chicken caecal fermentations revealed that SBM was associated with a higher relative abundance of Enterobacteriaceae, while wheat fermentation was associated with Lactobacillaceae and Enterococcaceae enrichment. Enzymatic supplementation with Rovabio™ Advance further enhanced wheat fermentation and bacterial community shifts, while its effect on SBM fermentation remained limited. In contrast, SBM pre-treatment with pectin-active fungal secretomes led to significantly increased short-chain fatty acid (SCFA) production and enriched SCFA-associated genera. These findings indicate that while industrial enzyme cocktails are well suited to cereal-based diets, targeted pectin-degrading enzymes could be seen as a promising strategy to enhance the prebiotic potential of SBM. This study highlights the importance of tailoring enzymatic solutions to feed carbohydrate composition, to improve gut microbiota function and promote intestinal health in poultry. KEY POINTS: • SBM does not induce intestinal cell inflammation or epithelium disruption in vitro. • Both SBM and wheat increase SCFA production by the chicken caecal microbiota. • Pre-treatment with fungal pectin-active secretomes enhance SBM's prebiotic potential.

Indexed as

Animal FeedCecumEnzymesEpithelial CellsGastrointestinal MicrobiomeGlycine maxAnimalsBacteriaCell LineChickensFatty Acids, VolatileFermentationIntestinal MucosaPectinsEnzymesFatty Acids, VolatilePectinsCAZymesChicken intestinal healthEnzymesFungal secretomesPectinShort-chain fatty acidsSoybean meal

Identifiers

PMID42334588
PMCPMC13542025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.